Journal September 26, 2026 4 min read

How does proteostasis work?

Proteostasis is the integrated network of pathways that maintain protein folding, trafficking, and degradation. This page outlines its core components and summarizes research on its role in disease models.

peptides-pro Editorial

Proteostasis: Core Components and Pathways

Proteostasis, or protein homeostasis, is the collective set of cellular processes that maintain the proteome in a functional state. It encompasses protein synthesis, folding, trafficking, post-translational modification, and degradation. The primary degradation routes are the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway. Disruption of proteostasis is implicated in numerous age-related and neurodegenerative conditions [1].

Research on proteostasis centers on the heat shock protein (HSP) chaperone family, the ubiquitin-proteasome system, and autophagy-lysosomal machinery. Key regulators include the chaperonin CCT/TRiC and mitochondrial quality control proteases such as HtrA2 [5][6].

Research Studies

Proteostasis and astrocytic failure in Parkinson's disease models

In a system-level model of Parkinson's disease (PD), pathological α-synuclein was reported to trigger a cycle of astrocytic failure that includes impaired proteostasis via ubiquitin-proteasome and autophagy-lysosomal pathways. This astrocytopathy was proposed as an active driver of pathogenesis, extending beyond a passive bystander role [1].

CCT/TRiC and therapy-induced senescence in glioblastoma multiforme

Glioblastoma multiforme (GBM) is described as chaperone-dependent, relying on proteostasis networks for growth, invasion, and treatment resistance. The eukaryotic chaperonin CCT/TRiC has been implicated in shaping therapy-induced senescence (TIS) in GBM, a state marked by permanent proliferation arrest and a senescence-associated secretory phenotype (SASP) [5].

Mitochondrial quality control and senescence in mouse embryonic fibroblasts

In mouse embryonic fibroblasts (MEFs) deficient in the mitochondrial protease HtrA2 (a proteostasis component), the transcription factor Chop (integrated stress response), or the mitophagy regulator Pink1, researchers examined senescence induction following genotoxic challenge. The study investigated how mitochondrial quality control and stress signalling modulate DNA damage-induced senescence [6].

Circadian regulation of proteostasis in Alzheimer's disease

Mechanistic studies suggest interactions between core clock genes and neurodegenerative cascades involving oxidative stress, neuroinflammation, glial reactivity, and proteostasis in Alzheimer's disease (AD). Disruptions in circadian-regulated pathways, including BMAL1-SIRT1 and NF-κB-NLRP3, have been linked to AD pathogenesis [7].

NMNAT-1 and NAD+ homeostasis in neuroprotection

Nicotinamide mononucleotide adenylyltransferase 1 (NMNAT-1) catalyzes the final step in NAD+ biosynthesis and is the major nuclear isoform of the mammalian NMNAT family. Direct human genetic evidence establishes NMNAT-1 as a causal gene in inherited axonal degeneration. Age-associated NAD+ decline has been implicated in brain aging and neurodegenerative disorders [4].

Proteostasis in bone aging

Bone aging is characterized as a multi-level degenerative phenomenon spanning molecular, cellular, tissue, and system levels. While proteostasis is not the primary focus, the review synthesizes mechanisms of bone degeneration that may intersect with protein quality control [2].

Anabolic resistance and proteostasis in uremia

In advanced chronic kidney disease (CKD), protein-energy wasting (PEW) is associated with a "nutritional paradox" where standard nutritional interventions are often insufficient due to systemic anabolic resistance. The proposed model suggests a molecular hierarchy that impedes nutritional therapy, potentially involving proteostasis mechanisms [3].

Plant cell proteostasis under salinity stress

In plants, salinity stress induces osmotic imbalance, ionic toxicity, and oxidative stress. Structural and functional cellular protectors, including the cell wall, plasma membrane, vacuole, and peroxisome, maintain homeostasis under saline conditions. While not directly addressing proteostasis, this review outlines adaptive strategies that may involve protein protection [8].

Comparative overview of proteostasis-related pathways

Pathway/Component	Role	Model/Context
Ubiquitin-proteasome system	Degradation of misfolded proteins	Astrocytes in PD [1]
Autophagy-lysosomal pathway	Bulk degradation and recycling	Astrocytes in PD [1]
CCT/TRiC chaperonin	Protein folding	GBM [5]
HtrA2 protease	Mitochondrial proteostasis	MEFs [6]
NMNAT-1	NAD+ biosynthesis	Neuroprotection [4]

If you are reading this for personal health reasons

The materials and information discussed here are sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.